Cataract Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Cataract Surgery Devices Pipeline Market Report Overview

Cataract surgery is the removal of the natural lens of the eye that has developed an opacification and is then replacing it with an artificial intraocular lens to restore transparency. The cataract surgery devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Segments ·       Femtosecond Laser

·       Phacoemulsification Equipment and Accessories

Key Territories ·       The US

·       Europe

·       China

·       India

·       Israel

Key Regulatory Paths ·       510(k)

·       CE

·       ICAC

·       NMPA

Leading Companies ·       Advanced Refractive Technologies Inc.

·       Alcon Inc.

·       Altacor Ltd

·       Bausch & Lomb Inc.

·       Carl Zeiss Meditec AG

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Cataract Surgery Devices Pipeline Market by Segments

The key segments of the cataract surgery devices pipeline market are femtosecond laser and phacoemulsification equipment and accessories. As of September 2024, both segments had an equal share in the market.

Cataract Surgery Devices Pipeline Market Analysis by Segments, 2024 (%)

Cataract Surgery Devices Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segment Insights into the Cataract Surgery Devices Pipeline Market

Download a Free Report Sample

Cataract Surgery Devices Pipeline Market Segmentation by Territories

A few of the key territories with the cataract surgery devices pipeline market are the US, Europe, China, India, and Israel. As of September 2024, the US accounted for the highest number of pipeline products.

Cataract Surgery Devices Pipeline Market Analysis by Territories, 2024 (%)

Cataract Surgery Devices Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Cataract Surgery Devices Pipeline Market

Download a Free Report Sample

Cataract Surgery Devices Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the cataract surgery devices pipeline products market are 510(k), CE, ICAC, and NMPA. As of September 2024, 510(k) was the most followed pathway for pipeline products in the cataract surgery devices market.

Cataract Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Cataract Surgery Devices Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Cataract Surgery Devices Pipeline Market

Download a Free Report Sample

Cataract Surgery Devices Pipeline Market – Competitive Landscape

A few of the key companies associated with the cataract surgery devices pipeline market are Advanced Refractive Technologies Inc., Alcon Inc., Altacor Ltd, Bausch & Lomb Inc., and Carl Zeiss Meditec AG, among others.

Advanced Refractive Technologies Inc (ART): Headquartered in San Clemente, California, the US, it is a medical device manufacturer. The company designs, develops, manufactures, and markets ophthalmic devices and pharmaceutical agents for the ophthalmology market. The company’s products include pharmaceutical agents, medical devices, and accupulse cataract emulsifier devices.

Alcon Inc: Headquartered in Fribourg, Switzerland, it is engaged in the development and manufacturing of devices in the field of ophthalmology. The company’s portfolio encompasses contact lenses and surgical products, including implantables, consumables, and surgical equipment. Its products are indicated for the treatment of various conditions such as cataracts, glaucoma, retinal diseases, and refractive errors. Alcon Inc. conducts clinical trials to evaluate the safety and efficacy of its products for the prevention and cure of blindness and different eye diseases.

Cataract Surgery Devices Pipeline Market Analysis by Companies, 2024

Cataract Surgery Devices Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Cataract Surgery Devices Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Cataract Surgery Devices Pipeline Market Segments Outlook (2024)

  • Femtosecond Laser
  • Phacoemulsification Equipment and Accessories

Cataract Surgery Devices Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • India
  • Israel

Cataract Surgery Devices Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE
  • ICAC
  • NMPA

Scope

This report provides:

  • Extensive coverage of the cataract surgery devices under development.
  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of cataract surgery devices and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of cataract surgery devices under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Advanced Refractive Technologies Inc
Alcon Inc
Altacor Ltd
Bausch & Lomb Inc
Carl Zeiss Meditec AG
Centricity Vision Inc
Cirle, Inc
ClearSight Innovations Limited
Edinburgh Biosciences Ltd
Eye Care and Cure
International BioMedical Devices Inc
Medical University of Vienna
Medicontur Medical Engineering Ltd
OptoLight Vision Technology
Paradigm Medical Industries, Inc. (Inactive)
STAAR Surgical Co
Tear Diagno LLC (Inactive)
Tupai (Beijing) Medical Technology Co Ltd
University of California Los Angeles
University of Colorado Anschutz Medical Campus
University of Florida
University of Michigan
University of Texas Medical Branch at Galveston
Wake Forest Baptist Medical Center

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Cataract Surgery Devices Overview

3 Products under Development

3.1 Cataract Surgery Devices – Pipeline Products by Stage of Development

3.2 Cataract Surgery Devices – Pipeline Products by Segment

3.3 Cataract Surgery Devices – Pipeline Products by Territory

3.4 Cataract Surgery Devices – Pipeline Products by Regulatory Path

3.5 Cataract Surgery Devices – Pipeline Products by Estimated Approval Date

3.6 Cataract Surgery Devices – Ongoing Clinical Trials

4 Cataract Surgery Devices – Pipeline Products under Development by Companies

4.1 Cataract Surgery Devices Companies – Pipeline Products by Stage of Development

4.2 Cataract Surgery Devices – Pipeline Products by Stage of Development

5 Cataract Surgery Devices Companies and Product Overview

5.1 Advanced Refractive Technologies Inc Company Overview

5.1.1 Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.2 Alcon Inc Company Overview

5.2.1 Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 Altacor Ltd Company Overview

5.3.1 Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.4 Bausch & Lomb Inc Company Overview

5.4.1 Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Carl Zeiss Meditec AG Company Overview

5.5.1 Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview

5.6 Centricity Vision Inc Company Overview

5.6.1 Centricity Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

5.7 Cirle, Inc Company Overview

5.7.1 Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview

5.8 ClearSight Innovations Limited Company Overview

5.8.1 ClearSight Innovations Limited Pipeline Products & Ongoing Clinical Trials Overview

5.9 Edinburgh Biosciences Ltd Company Overview

5.9.1 Edinburgh Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.10 Eye Care and Cure Company Overview

5.10.1 Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview

5.11 International BioMedical Devices Inc Company Overview

5.11.1 International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview

5.12 Medical University of Vienna Company Overview

5.12.1 Medical University of Vienna Pipeline Products & Ongoing Clinical Trials Overview

5.13 Medicontur Medical Engineering Ltd Company Overview

5.13.1 Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.14 OptoLight Vision Technology Company Overview

5.14.1 OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview

5.15 Paradigm Medical Industries, Inc. (Inactive) Company Overview

5.15.1 Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.16 STAAR Surgical Co Company Overview

5.16.1 STAAR Surgical Co Pipeline Products & Ongoing Clinical Trials Overview

5.17 Tear Diagno LLC (Inactive) Company Overview

5.17.1 Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.18 Tupai (Beijing) Medical Technology Co Ltd Company Overview

5.18.1 Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.19 University of California Los Angeles Company Overview

5.19.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

5.20 University of Colorado Anschutz Medical Campus Company Overview

5.20.1 University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview

5.21 University of Florida Company Overview

5.21.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview

5.22 University of Michigan Company Overview

5.22.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

5.23 University of Texas Medical Branch at Galveston Company Overview

5.23.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview

5.24 Wake Forest Baptist Medical Center Company Overview

5.24.1 Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview

6 Cataract Surgery Devices- Recent Developments

6.1 Sep 12, 2024: MellingMedical Signs NX Contracts to Source Topcon Devices

6.2 Aug 22, 2024: Eyebright Medical Technology Reports Financial Results for H1 of 2024

6.3 Aug 20, 2024: Alcon Announces Results for Three and Six Month Periods Ending June 30, 2024

6.4 Aug 06, 2024: Santen Pharma Announces Consolidated Financial Results for the Three Months Ended June 30, 2024

6.5 Aug 05, 2024: Bausch & Lomb Receives Additional 510(k) Clearance For Stellaris Elite Vision Enhancement System

6.6 Aug 01, 2024: LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024

6.7 Jul 23, 2024: Mann Eye Institute Introduces Cutting-Edge miCOR Technology for Advanced Cataract Surgery

6.8 Jul 04, 2024: Alcon Receives 510(K) Clearance For UNITY CS (8065000297)

6.9 Jul 02, 2024: Alcon Receives 510(K) Clearance For UNITY Vitreoretinal Cataract System

6.10 Jun 14, 2024: Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its

2.75% Convertible Senior Notes Due 2027 for Common Stock

6.11 Jun 10, 2024: NIDEK receives CE mark approval for the new preloaded IOL injection system

6.12 Apr 15, 2024: Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

6.13 Apr 09, 2024: Verana Health to Reveal Results from Largest Pediatric Intraocular Lens Study, Funded by the FDA, During AAPOS 2024

6.14 Apr 04, 2024: STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024

6.15 Mar 07, 2024: Bausch & Lomb Receives Additional FDA 510(k) Clearance for Stellaris Elite Vision Enhancement System

6.16 Mar 06, 2024: STAAR Surgical to Participate in Two Upcoming Investor Conferences

6.17 Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024

6.18 Jan 29, 2024: Alcon Receives 510(K) Clearance For CENTURION Vision System

6.19 Nov 01, 2023: Centricity Vision Announces Commercial Launch of ZEPTOLink IOL Positioning System at AAO Conference

6.20 Oct 24, 2023: Ocular Therapeutix to Report Third Quarter 2023 Financial Results

6.21 Oct 10, 2023: Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023

6.22 Oct 09, 2023: Medicel AG Receives 510(k) Clearance for Accuject Refra Injector AR2900

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Cataract Surgery Devices – Pipeline Products by Stage of Development

Cataract Surgery Devices – Pipeline Products by Segment

Cataract Surgery Devices – Pipeline Products by Territory

Cataract Surgery Devices – Pipeline Products by Regulatory Path

Cataract Surgery Devices – Pipeline Products by Estimated Approval Date

Cataract Surgery Devices – Ongoing Clinical Trials

Cataract Surgery Devices Companies – Pipeline Products by Stage of Development

Cataract Surgery Devices – Pipeline Products by Stage of Development

Advanced Refractive Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Accupulse Cataract Emulsifier – Product Status

Accupulse Cataract Emulsifier – Product Description

Alcon Inc Pipeline Products & Ongoing Clinical Trials Overview

Novel Delivery System – Product Status

Novel Delivery System – Product Description

UNITY CS (8065000297) – Product Status

UNITY CS (8065000297) – Product Description

UNITY VCS (8065000296) – Product Status

UNITY VCS (8065000296) – Product Description

WaveLight UV-Femtosecond Laser System (Model-1026) – Product Status

WaveLight UV-Femtosecond Laser System (Model-1026) – Product Description

Alcon Inc – Ongoing Clinical Trials Overview

WaveLight UV-Femtosecond Laser System (Model-1026) – Clinical Investigation of the Wavelight UV Femtosecond Laser for Corneal Flap Creation

WaveLight UV-Femtosecond Laser System (Model-1026) – Contralateral Study of the WaveLight® Ultraviolet Femtosecond Laser, Model 1026 Versus the WaveLight FS200 Infrared Femtosecond Laser, Model 1025 for Corneal Flap Creation

WaveLight UV-Femtosecond Laser System (Model-1026) – UV Femtosecond Laser Assisted Lenticule Extraction Sphere Nomogram Study

Altacor Ltd Pipeline Products & Ongoing Clinical Trials Overview

SOLO – Product Status

SOLO – Product Description

Bausch & Lomb Inc Pipeline Products & Ongoing Clinical Trials Overview

BLS – 001: Cataract – Product Status

BLS – 001: Cataract – Product Description

BLS – 002: Cataract – Product Status

BLS – 002: Cataract – Product Description

BLS – 003: Cataract – Product Status

BLS – 003: Cataract – Product Description

BLS – 004: Cataract – Product Status

BLS – 004: Cataract – Product Description

BLS – 006: Cataract – Product Status

BLS – 006: Cataract – Product Description

BLS – 007: Cataract – Product Status

BLS – 007: Cataract – Product Description

BLS – 008: Cataract – Product Status

BLS – 008: Cataract – Product Description

BLS – 010: Cataract – Product Status

BLS – 010: Cataract – Product Description

BLS – 011: Cataract – Product Status

BLS – 011: Cataract – Product Description

BLS – 015: Cataract – Product Status

BLS – 015: Cataract – Product Description

BLS – 016: Cataract – Product Status

BLS – 016: Cataract – Product Description

Carl Zeiss Meditec AG Pipeline Products & Ongoing Clinical Trials Overview

Cataract Surgery Device – Product Status

Cataract Surgery Device – Product Description

Centricity Vision Inc Pipeline Products & Ongoing Clinical Trials Overview

Zepto-PEDS – Product Status

Zepto-PEDS – Product Description

Cirle, Inc Pipeline Products & Ongoing Clinical Trials Overview

SNS 200 – Product Status

SNS 200 – Product Description

ClearSight Innovations Limited Pipeline Products & Ongoing Clinical Trials Overview

Mirricon – Product Status

Mirricon – Product Description

Edinburgh Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview

LEDINBIO – Product Status

LEDINBIO – Product Description

Edinburgh Biosciences Ltd – Ongoing Clinical Trials Overview

LEDINBIO – Study on the Performance and Safety of the CATACURE-I Non-Invasive treatment Device In Subjects with Age related Cataract

LEDINBIO – Study On the Performance and Safety of the LEDINBIO CE Device On Visual Acuity in Subjects with Cataract

Eye Care and Cure Pipeline Products & Ongoing Clinical Trials Overview

Ophthalmic Device – Cataract Surgery – Product Status

Ophthalmic Device – Cataract Surgery – Product Description

International BioMedical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview

ApertureRx Precision Capsulotomy System – Product Status

ApertureRx Precision Capsulotomy System – Product Description

Medical University of Vienna Pipeline Products & Ongoing Clinical Trials Overview

Fixation Clip – Product Status

Fixation Clip – Product Description

Medicontur Medical Engineering Ltd Pipeline Products & Ongoing Clinical Trials Overview

Pre-Filled Injection System – Product Status

Pre-Filled Injection System – Product Description

OptoLight Vision Technology Pipeline Products & Ongoing Clinical Trials Overview

Lipshitz Macular Implant – Diabetic Maculopathy – Product Status

Lipshitz Macular Implant – Diabetic Maculopathy – Product Description

Paradigm Medical Industries, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Photon Laser System – Product Status

Photon Laser System – Product Description

STAAR Surgical Co Pipeline Products & Ongoing Clinical Trials Overview

Preloaded Injector System – Collamer IOL – Product Status

Preloaded Injector System – Collamer IOL – Product Description

Tear Diagno LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Cataract Surgical Device – Product Status

Cataract Surgical Device – Product Description

Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Full Femtosecond Laser – Product Status

Full Femtosecond Laser – Product Description

University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview

Intraocular Robotic Interventional Surgical System (IRISS) – Product Status

Intraocular Robotic Interventional Surgical System (IRISS) – Product Description

University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview

Intraocular Prosthetic With Foot Plates – Product Status

Intraocular Prosthetic With Foot Plates – Product Description

University of Florida Pipeline Products & Ongoing Clinical Trials Overview

Intraocular Lens Removal Device – Product Status

Intraocular Lens Removal Device – Product Description

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

Surgical Knife – Product Status

Surgical Knife – Product Description

University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview

Ocular Surgery Device – Product Status

Ocular Surgery Device – Product Description

Wake Forest Baptist Medical Center Pipeline Products & Ongoing Clinical Trials Overview

Aspiration And Irrigation Handpiece Tip – Product Status

Aspiration And Irrigation Handpiece Tip – Product Description

Glossary

Figures

Cataract Surgery Devices – Pipeline Products by Stage of Development

Cataract Surgery Devices – Pipeline Products by Segment

Cataract Surgery Devices – Pipeline Products by Territory

Cataract Surgery Devices – Pipeline Products by Regulatory Path

Cataract Surgery Devices – Pipeline Products by Estimated Approval Date

Cataract Surgery Devices – Ongoing Clinical Trials

Frequently asked questions

Cataract Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Cataract Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Cataract Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Cataract Surgery Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.